Skip to content
Pain Dr.
  • Articles
  • Q&A’s
    • Opioids
    • Tox Screens
    • Alternatives
  • Services
    • Virtual Consultations
    • Expert Witness
    • Lectures, Speaking, & Writing
    • Risk Evaluation Mitigation Strategies (REMS) Education
  • Resources
    • Opioid Toolbox
      • Opioid Calculator
      • Conversion Unscrambled
      • Methadone
      • Fudin Factor
    • Quick References
    • Suggested Readings
    • Links & Projects
      • PGY2 Pharmacy Pain Residency
  • About PainDr.com
    • Meet Dr. Fudin
    • The Team
  • Contact Me
Uncategorized

Simon, Howie and Mitch (and Dan and Art and Margo and Ken)

February 22, 2019 / / Leave a Comment on Simon, Howie and Mitch (and Dan and Art and Margo and Ken)

Over recent years, the pain community has lost several incredibly stellar clinicians all of whom dedicated their lives to caring…

Read More

Uncategorized

Happy Holidays or Horrific Hoax?

December 26, 2018December 26, 2018 / / 16 Comments on Happy Holidays or Horrific Hoax?

Happy New Year CMS, Buprenorphine and Tapentadol As many of you already know, the Centers for Medicare & Medicaid Services…

Read More

Uncategorized

Should alcohol monitoring be a standard of care when prescribing opioids?

February 18, 2016February 18, 2016 / / 10 Comments on Should alcohol monitoring be a standard of care when prescribing opioids?

Several opioid prescribing guidelines suggest or require that urine drug testing be the standard of care when prescribing chronic opioid…

Read More

Uncategorized

Good, Bad, and Ugly of CDC Proposed Opioid Guidelines

October 23, 2015October 23, 2015 / / 19 Comments on Good, Bad, and Ugly of CDC Proposed Opioid Guidelines

Anyone reading this is likely familiar with the “confidential” proposed CDC Guideline for Prescribing Opioids for Chronic Pain”. Before even…

Read More

Blog, Opioids, Opioids & Politics, PROMPT (Professionals for Rational Opioid Monitoring & PharmacoTherapy), Uncategorized

Dr. Bob Twillman Critiques FDA Opioid Hearing

February 10, 2013June 1, 2019 / / 16 Comments on Dr. Bob Twillman Critiques FDA Opioid Hearing

Bob Twillman, PhD, FAPM is the Director of Policy and Advocacy for the American Academy of Pain Management.  A complete…

Read More

Blog, Opioids, Opioids & Politics, Resident & Student Posts, Uncategorized

ISTOP: Progress in NYS, Opioid Abuse & Diversion

October 9, 2012November 1, 2012 / / 7 Comments on ISTOP: Progress in NYS, Opioid Abuse & Diversion

Guest Blogger: Anthony Debboli, Pharm.D. Candidate 2013 ACPHS.   Guest posts by Resident and Intern Pharmacists are reviewed, edited, and approved…

Read More

Article Categories

Recent Articles

  • Oleandrin is dangerous and not a cure for COVID-19         
  • Which magnesium supplement is right for me?
  • Uncovering Illicit Use of Gabapentinoids in a Patient with Several Comorbidities

Q&A Categories

Latest Q&A's

  • how-long-to-transition-kratom-to-remeron asked by Kathy
  • what-is-in-xtampza-i-hate-it-says-oxycodone-but-much-more asked by Jacquelyn Jones
  • i-cant-feel-180-mg-of-liquid-methadone-taken-daily asked by Michael Westmoreland

Social Media

  • facebook
  • twitter
  • linkedin

Legal Information

  • Privacy Policy
Copyright © 2026 Remitigate, LLC. All rights reserved.
Brought to Life by Glueware
PainDr.com logo vector created by yurlick - www.freepik.com